Temat: "Leukemia-Lymphoma" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Evaluation of Novel Targets, Including CC-Chemokine Receptor 4, in Adult T-Cell Acute Lymphoblastic Leukemia/Lymphoma: A Mayo Clinic Clinical and Pathologic Study.
Autorzy:: Khurana S; From the Division of Hematology/Oncology, University of Arizona Cancer Center, Tucson (Khurana).
Heckman MG; the Departments of Biomedical Statistics and Informatics (Heckman, Cochuyt) and Laboratory Medicine and Pathology (Jiang), and the Division of Hematology and Medical Oncology (Foran), Mayo Clinic Florida, Jacksonville.
Craig FE; the Divisions of Hematopathology (Craig) and Hematology and Medical Oncology (Sproat), Mayo Clinic Arizona, Phoenix.
Cochuyt JJ; the Departments of Biomedical Statistics and Informatics (Heckman, Cochuyt) and Laboratory Medicine and Pathology (Jiang), and the Division of Hematology and Medical Oncology (Foran), Mayo Clinic Florida, Jacksonville.
Greipp P; the Divisions of Laboratory Genetics (Greipp) and Hematology (Litzow), Mayo Clinic, Rochester, Minnesota.
Rahman ZA; the Division of Hematology and Medical Oncology, Sanford Roger Maris Cancer Center, Fargo, North Dakota (Rahman).
Sproat LZ; the Divisions of Hematopathology (Craig) and Hematology and Medical Oncology (Sproat), Mayo Clinic Arizona, Phoenix.
Litzow M; the Divisions of Laboratory Genetics (Greipp) and Hematology (Litzow), Mayo Clinic, Rochester, Minnesota.
Foran JM; the Departments of Biomedical Statistics and Informatics (Heckman, Cochuyt) and Laboratory Medicine and Pathology (Jiang), and the Division of Hematology and Medical Oncology (Foran), Mayo Clinic Florida, Jacksonville.
Jiang LJ; the Departments of Biomedical Statistics and Informatics (Heckman, Cochuyt) and Laboratory Medicine and Pathology (Jiang), and the Division of Hematology and Medical Oncology (Foran), Mayo Clinic Florida, Jacksonville.; Pokaż więcej
Źródło:: Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2024 Apr 01; Vol. 148 (4), pp. 471-475.
Typ publikacji:: Journal Article
MeSH Terms:: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/pathology
Lymphoma*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/pathology
Lymphoma, B-Cell*
Adult ; Humans ; CD47 Antigen ; Receptors, CCR4 ; Interleukin-3 Receptor alpha Subunit ; T-Lymphocytes/pathology ; Proto-Oncogene Proteins c-bcl-2

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Low expression of miR-182 caused by DNA hypermethylation accelerates acute lymphocyte leukemia development by targeting PBX3 and BCL2: miR-182 promoter methylation is a predictive marker for hypomethylation agents + BCL2 inhibitor venetoclax.
Autorzy:: Li D; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China.
Yuan Y; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China.
Meng C; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China.
Lin Z; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China.
Zhao M; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China.
Shi L; Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, Zhejiang Province, China.
Li M; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China.
Ye D; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China.
Cai Y; Department of Clinical Medicine, Wenzhou Medical University, Chashan District, Wenzhou, Zhejiang Province, China.
He X; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China.; The Key Laboratory of Pediatric Hematology and Oncology Diseases of Wenzhou, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, 109 Xuanyuanxi Road, Wenzhou, Zhejiang Province, China.
Ye H; Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, Zhejiang Province, China.
Zhou S; Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, Zhejiang Province, China.
Zhou H; The Key Laboratory of Pediatric Hematology and Oncology Diseases of Wenzhou, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, 109 Xuanyuanxi Road, Wenzhou, Zhejiang Province, China. .; Department of Hematology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, 109 Xuanyuanxi Road, Wenzhou, Zhejiang Province, China. .
Gao S; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China. .; The Key Laboratory of Pediatric Hematology and Oncology Diseases of Wenzhou, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, 109 Xuanyuanxi Road, Wenzhou, Zhejiang Province, China. .; Pokaż więcej
Źródło:: Clinical epigenetics [Clin Epigenetics] 2024 Mar 26; Vol. 16 (1), pp. 48. Date of Electronic Publication: 2024 Mar 26.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Antineoplastic Agents*/pharmacology
MicroRNAs*/genetics
MicroRNAs*/metabolism
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Adult ; Animals ; Humans ; Mice ; Bridged Bicyclo Compounds, Heterocyclic/therapeutic use ; DNA Methylation/genetics ; Lymphocytes/metabolism ; Mice, Knockout ; Proto-Oncogene Proteins c-bcl-2/genetics ; Proto-Oncogene Proteins c-bcl-2/metabolism ; Sulfonamides/therapeutic use ; Homeodomain Proteins/genetics ; Homeodomain Proteins/metabolism ; Proto-Oncogene Proteins/genetics ; Proto-Oncogene Proteins/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Clinicopathological features of adult T-cell leukemia/lymphoma with T-follicular helper phenotype.
Autorzy:: Muto R; Department of Pathology, National Hospital Organization (NHO), Kumamoto Medical Center, Kumamoto, Japan.; Department of Pathology, Kurume University School of Medicine, Kurume, Japan.; Department of Pathology, Fukuoka University School of Medicine, Fukuoka, Japan.
Miyoshi H; Department of Pathology, Kurume University School of Medicine, Kurume, Japan.
Nakashima K; Department of Pathology, Kurume University School of Medicine, Kurume, Japan.
Takeuchi M; Department of Pathology, Kurume University School of Medicine, Kurume, Japan.
Hamasaki M; Department of Pathology, Fukuoka University School of Medicine, Fukuoka, Japan.
Ohshima K; Department of Pathology, Kurume University School of Medicine, Kurume, Japan.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2024 Mar; Vol. 13 (6), pp. e7050.
Typ publikacji:: Journal Article
MeSH Terms:: Leukemia-Lymphoma, Adult T-Cell*/diagnosis
Leukemia-Lymphoma, Adult T-Cell*/genetics
Lymphoma*/pathology
Adult ; Humans ; Prognosis ; Phenotype ; T-Lymphocytes, Helper-Inducer/metabolism ; T-Lymphocytes, Helper-Inducer/pathology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Targeting autophagy as a therapeutic strategy in pediatric acute lymphoblastic leukemia.
Autorzy:: Bwanika HC; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.
Leo IR; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.; Science for Life Laboratory, Solna, Sweden.
Struyf N; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.; Science for Life Laboratory, Solna, Sweden.
Talanti A; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.
Aswad L; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.; Science for Life Laboratory, Solna, Sweden.
Konnur A; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.
Björklund AC; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.; Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institute, Huddinge, Sweden.
Heyman M; Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Rassidakis G; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.
Erkers T; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.; Science for Life Laboratory, Solna, Sweden.
Seashore-Ludlow B; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.; Science for Life Laboratory, Solna, Sweden.
Jafari R; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.; Science for Life Laboratory, Solna, Sweden.
Pokrovskaja Tamm K; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Feb 18; Vol. 14 (1), pp. 4000. Date of Electronic Publication: 2024 Feb 18.
Typ publikacji:: Journal Article
MeSH Terms:: Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/pathology
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Child ; Humans ; Autophagy ; Cell Line ; Glucocorticoids/therapeutic use ; Cell Line, Tumor ; Apoptosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Neuropsychological task outcomes among survivors of childhood acute lymphoblastic leukemia in Malaysia.
Autorzy:: Alias H; Department of Pediatrics, Faculty of Medicine, The National University of Malaysia, 56000, Cheras, Kuala Lumpur, Malaysia. .
Mohd Ranai N; Department of Pediatrics, Faculty of Medicine, Universiti Teknologi Mara (UiTM), 47000, Shah Alam, Selangor, Malaysia.
Lau SCD; Department of Pediatrics, Faculty of Medicine, The National University of Malaysia, 56000, Cheras, Kuala Lumpur, Malaysia.
de Sonneville LMJ; Clinical Neurodevelopmental Sciences, Faculty of Social Sciences, Leiden University, Wassenaarseweg 52, 2333 AK, Leiden, The Netherlands.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Apr 04; Vol. 14 (1), pp. 7915. Date of Electronic Publication: 2024 Apr 04.
Typ publikacji:: Journal Article
MeSH Terms:: Executive Function*/physiology
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/complications
Humans ; Child, Preschool ; Child ; Malaysia/epidemiology ; Case-Control Studies ; Neuropsychological Tests ; Survivors/psychology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Infant Acute Lymphoblastic Leukemia-New Therapeutic Opportunities.
Autorzy:: Kulczycka M; Student Scientific Society of Department of Pediatric Hematology, Oncology and Transplantology, Medical University of Lublin, 20-093 Lublin, Poland.
Derlatka K; Student Scientific Society of Department of Pediatric Hematology, Oncology and Transplantology, Medical University of Lublin, 20-093 Lublin, Poland.
Tasior J; Student Scientific Society of Department of Pediatric Hematology, Oncology and Transplantology, Medical University of Lublin, 20-093 Lublin, Poland.
Sygacz M; Student Scientific Society of Department of Pediatric Hematology, Oncology and Transplantology, Medical University of Lublin, 20-093 Lublin, Poland.
Lejman M; Independent Laboratory of Genetic Diagnostics, Medical University of Lublin, 20-093 Lublin, Poland.
Zawitkowska J; Department of Pediatric Hematology, Oncology and Transplantology, Medical University of Lublin, 20-093 Lublin, Poland.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 27; Vol. 25 (7). Date of Electronic Publication: 2024 Mar 27.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Immunotherapy*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/therapy
Infant ; Humans ; Child ; Adolescent ; Molecular Targeted Therapy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Fatigue in children who have recently completed treatment for acute lymphoblastic leukemia: a longitudinal study.
Autorzy:: Walsh S; Institute for Social Neuroscience, ISN Psychology, Heidelberg, VIC, Australia.; Clinical Sciences, Murdoch Children's Research Institute, Melbourne, VIC, Australia.
Mulraney M; Institute for Social Neuroscience, ISN Psychology, Heidelberg, VIC, Australia.; Clinical Sciences, Murdoch Children's Research Institute, Melbourne, VIC, Australia.; Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia.
McCarthy MC; Clinical Sciences, Murdoch Children's Research Institute, Melbourne, VIC, Australia.; Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia.; Children's Cancer Centre, Royal Children's Hospital, 50 Flemington Road, Parkville, VIC, 3052, Australia.
De Luca CR; Clinical Sciences, Murdoch Children's Research Institute, Melbourne, VIC, Australia. .; Children's Cancer Centre, Royal Children's Hospital, 50 Flemington Road, Parkville, VIC, 3052, Australia. .; Pokaż więcej
Źródło:: Health and quality of life outcomes [Health Qual Life Outcomes] 2024 Mar 22; Vol. 22 (1), pp. 27. Date of Electronic Publication: 2024 Mar 22.
Typ publikacji:: Journal Article
MeSH Terms:: Quality of Life*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/complications
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/psychology
Child ; Humans ; Longitudinal Studies ; Fatigue/psychology ; Self Report

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Reduced-dose chemotherapy followed by blinatumomab in induction therapy for newly diagnosed B-cell acute lymphoblastic leukemia.
Autorzy:: Lu J; Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Suzhou, China.
Zhou H; Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Suzhou, China.
Zhou X; Department of Hematology, Wuxi People's Hospital Affiliated to Nanjing Medical University, WuXi, China.
Yang Y; Department of Hematology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
Tong L; Yixing People's Hospital, The Affiliated Hospital of Jiangsu University, Yixing, China.
Miao M; Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Suzhou, China.
Yang X; Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Suzhou, China.
Chen S; Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Suzhou, China.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2024 Mar; Vol. 13 (5), pp. e7062.
Typ publikacji:: Journal Article
MeSH Terms:: Antibodies, Bispecific*/adverse effects
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Burkitt Lymphoma*/drug therapy
Humans ; Retrospective Studies ; Induction Chemotherapy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Importance of Rare Gene Alterations in the Prognosis of B-Cell Acute Lymphoblastic Leukemia
Autorzy:: Xiang L; Zhejiang Provincial People’s Hospital Bijie Hospital, Department of Science and Education, Bijie, China
Wang Y; Xinchang Hospital Affiliated to Wenzhou Medical University, Department of Thoracic Surgery, Xinchang, China
Pan W; Haiyan People’s Hospital, Department of Clinical Laboratory, Haiyan, China; Pokaż więcej
Źródło:: Turkish journal of haematology : official journal of Turkish Society of Haematology [Turk J Haematol] 2024 Mar 01; Vol. 41 (1), pp. 49-50. Date of Electronic Publication: 2024 Jan 04.
Typ publikacji:: Journal Article
MeSH Terms:: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Burkitt Lymphoma*
Humans ; Prognosis

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Clinical and Real-World Effectiveness of Mogamulizumab: A Narrative Review.
Autorzy:: Fernández-Guarino M; Dermatology Department, Hospital Universitario Ramón y Cajal, Instituto de Investigación Sanitaria Ramón y Cajal (Irycis), 28034 Madrid, Spain.
Ortiz P; Dermatology Department, Hospital 12 de Octubre, 28041 Madrid, Spain.
Gallardo F; Dermatology Department, Hospital del Mar, 08003 Barcelona, Spain.
Llamas-Velasco M; Dermatology Department, Hospital Universitario de la Princesa, Fundación de Investigación Biomédica de la Princesa, 28006 Madrid, Spain.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Feb 12; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 12.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Lymphoma, T-Cell, Cutaneous*/drug therapy
Mycosis Fungoides*/pathology
Sezary Syndrome*/pathology
Leukemia-Lymphoma, Adult T-Cell*/drug therapy
Leukemia-Lymphoma, Adult T-Cell*/pathology
Skin Neoplasms*/pathology
Antibodies, Monoclonal, Humanized*
Adult ; Humans

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Disseminated Nocardia nova in a child with relapsed acute lymphoblastic leukemia: a case report.
Autorzy:: Arahirwa V; University of North Carolina School of Medicine, Chapel Hill, USA. victor_.
Thahir S; University of North Carolina School of Medicine, Chapel Hill, USA.
Hernandez L; University of North Carolina School of Medicine, Chapel Hill, USA.
Willis ZI; University of North Carolina School of Medicine, Chapel Hill, USA.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Feb 01; Vol. 24 (1), pp. 154. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Nocardia*
Nocardia Infections*/diagnosis
Nocardia Infections*/drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/complications
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Male ; Child ; Humans ; Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use ; Anti-Bacterial Agents/therapeutic use
SCR Organism:: Nocardia nova

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Chemo-free treatment of adult patients with Ph-positive acute lymphoblastic leukemia: latest updates from the 2023 ASH annual meeting.
Autorzy:: Shi T; Department of Hematology, Beijing Chao-Yang Hospital, Capital Medical University, No. 8 Gongren Tiyuchang Nanlu, Chaoyang District, Beijing, 100020, China.
Zhu HH; Department of Hematology, Beijing Chao-Yang Hospital, Capital Medical University, No. 8 Gongren Tiyuchang Nanlu, Chaoyang District, Beijing, 100020, China. .; Chinese Institutes for Medical Research, Beijing, 100005, China. .; Pokaż więcej
Źródło:: Journal of hematology & oncology [J Hematol Oncol] 2024 Apr 16; Vol. 17 (1), pp. 18. Date of Electronic Publication: 2024 Apr 16.
Typ publikacji:: Review; Letter; Research Support, Non-U.S. Gov't
MeSH Terms:: Precursor Cell Lymphoblastic Leukemia-Lymphoma*/therapy
Adult ; Humans ; Prospective Studies ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Protein Kinase Inhibitors/therapeutic use ; Philadelphia Chromosome

Recenzja

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Deep learning assists in acute leukemia detection and cell classification via flow cytometry using the acute leukemia orientation tube.
Autorzy:: Cheng FM; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, China Medical University, Taichung, 404, Taiwan.
Lo SC; Artificial Intelligence Center, China Medical University Hospital, China Medical University, Taichung, 404, Taiwan.
Lin CC; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, China Medical University, Taichung, 404, Taiwan.
Lo WJ; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, China Medical University, Taichung, 404, Taiwan.
Chien SY; Artificial Intelligence Center, China Medical University Hospital, China Medical University, Taichung, 404, Taiwan.
Sun TH; Artificial Intelligence Center, China Medical University Hospital, China Medical University, Taichung, 404, Taiwan.
Hsu KC; Artificial Intelligence Center, China Medical University Hospital, China Medical University, Taichung, 404, Taiwan. .; School of Medicine, China Medical University, Taichung, 404, Taiwan. .; Neuroscience and Brain Disease Center, China Medical University, Taichung, 404, Taiwan. .; Department of Neurology, China Medical University Hospital, China Medical University, Taichung, 404, Taiwan. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Apr 09; Vol. 14 (1), pp. 8350. Date of Electronic Publication: 2024 Apr 09.
Typ publikacji:: Journal Article
MeSH Terms:: Deep Learning*
Leukemia, Myeloid, Acute*/diagnosis
Leukemia, Myeloid, Acute*/pathology
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/pathology
Humans ; Retrospective Studies ; Flow Cytometry/methods ; Artificial Intelligence ; Acute Disease ; Immunophenotyping

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: EP300-ZNF384 transactivates IL3RA to promote the progression of B-cell acute lymphoblastic leukemia.
Autorzy:: Hou Z; Department of Hematology, Liaoning Medical Center for Hematopoietic Stem Cell Transplantation, the Second Hospital of Dalian Medical University, Dalian, 116027, China. houzhijie_.; Liaoning Key Laboratory of Hematopoietic Stem Cell Transplantation and Translational Medicine, Dalian Key Laboratory of hematology, Diamond Bay institute of hematology, Blood Stem Cell Transplantation Institute, the Second Hospital of Dalian Medical University, Dalian, 116027, China. houzhijie_.; Department of Pediatric, Pediatric Oncology and Hematology Center, the Second Hospital of Dalian Medical University, Dalian, 116027, China. houzhijie_.; Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, 116044, China. houzhijie_.
Ren Y; Department of Hematology, Liaoning Medical Center for Hematopoietic Stem Cell Transplantation, the Second Hospital of Dalian Medical University, Dalian, 116027, China.; Liaoning Key Laboratory of Hematopoietic Stem Cell Transplantation and Translational Medicine, Dalian Key Laboratory of hematology, Diamond Bay institute of hematology, Blood Stem Cell Transplantation Institute, the Second Hospital of Dalian Medical University, Dalian, 116027, China.; Department of Pediatric, Pediatric Oncology and Hematology Center, the Second Hospital of Dalian Medical University, Dalian, 116027, China.
Zhang X; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, 116044, China.
Huang D; Department of Hematology, Liaoning Medical Center for Hematopoietic Stem Cell Transplantation, the Second Hospital of Dalian Medical University, Dalian, 116027, China.; Liaoning Key Laboratory of Hematopoietic Stem Cell Transplantation and Translational Medicine, Dalian Key Laboratory of hematology, Diamond Bay institute of hematology, Blood Stem Cell Transplantation Institute, the Second Hospital of Dalian Medical University, Dalian, 116027, China.; Department of Pediatric, Pediatric Oncology and Hematology Center, the Second Hospital of Dalian Medical University, Dalian, 116027, China.
Yan F; Department of Hematology, Liaoning Medical Center for Hematopoietic Stem Cell Transplantation, the Second Hospital of Dalian Medical University, Dalian, 116027, China.; Liaoning Key Laboratory of Hematopoietic Stem Cell Transplantation and Translational Medicine, Dalian Key Laboratory of hematology, Diamond Bay institute of hematology, Blood Stem Cell Transplantation Institute, the Second Hospital of Dalian Medical University, Dalian, 116027, China.; Department of Pediatric, Pediatric Oncology and Hematology Center, the Second Hospital of Dalian Medical University, Dalian, 116027, China.
Sun W; Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, 116044, China.
Zhang W; Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, 116044, China.
Zhang Q; Department of Pathology, Dalian Medical University, Dalian, 116044, China.
Fu X; Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, 116044, China.
Lang Z; Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, 116044, China.
Chu C; Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, 116044, China.
Zou B; Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, 116044, China.
Gao B; Department of Hematology, Liaoning Medical Center for Hematopoietic Stem Cell Transplantation, the Second Hospital of Dalian Medical University, Dalian, 116027, China.; Liaoning Key Laboratory of Hematopoietic Stem Cell Transplantation and Translational Medicine, Dalian Key Laboratory of hematology, Diamond Bay institute of hematology, Blood Stem Cell Transplantation Institute, the Second Hospital of Dalian Medical University, Dalian, 116027, China.; Department of Pediatric, Pediatric Oncology and Hematology Center, the Second Hospital of Dalian Medical University, Dalian, 116027, China.
Jin B; Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, 116044, China.
Kang Z; Department of Hematology, Liaoning Medical Center for Hematopoietic Stem Cell Transplantation, the Second Hospital of Dalian Medical University, Dalian, 116027, China. .; Liaoning Key Laboratory of Hematopoietic Stem Cell Transplantation and Translational Medicine, Dalian Key Laboratory of hematology, Diamond Bay institute of hematology, Blood Stem Cell Transplantation Institute, the Second Hospital of Dalian Medical University, Dalian, 116027, China. .; Department of Pediatric, Pediatric Oncology and Hematology Center, the Second Hospital of Dalian Medical University, Dalian, 116027, China. .
Liu Q; Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, 116044, China. .
Yan J; Department of Hematology, Liaoning Medical Center for Hematopoietic Stem Cell Transplantation, the Second Hospital of Dalian Medical University, Dalian, 116027, China. .; Liaoning Key Laboratory of Hematopoietic Stem Cell Transplantation and Translational Medicine, Dalian Key Laboratory of hematology, Diamond Bay institute of hematology, Blood Stem Cell Transplantation Institute, the Second Hospital of Dalian Medical University, Dalian, 116027, China. .; Department of Pediatric, Pediatric Oncology and Hematology Center, the Second Hospital of Dalian Medical University, Dalian, 116027, China. .; Pokaż więcej
Źródło:: Cell communication and signaling : CCS [Cell Commun Signal] 2024 Apr 02; Vol. 22 (1), pp. 211. Date of Electronic Publication: 2024 Apr 02.
Typ publikacji:: Journal Article
MeSH Terms:: Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Trans-Activators*/metabolism
Animals ; Humans ; Mice ; Doxorubicin ; E1A-Associated p300 Protein ; Interleukin-3 ; Interleukin-3 Receptor alpha Subunit

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Diagnostic Utility of GATA3 and ISL1 in Differentiating Neuroblastoma From Other Pediatric Malignant Small Round Blue Cell Tumors.
Autorzy:: Mohanty SK; Department of Pathology and Laboratory Medicine, Advanced Medical Research Institute, Bhubaneswar, Odisha, India.; Department of Pathology and Laboratory Medicine, CORE Diagnostics, Gurgaon, Delhi, India.
Diwaker P; Department of Pathology, University College of Medical Sciences, Delhi, India.
Mishra SK; Department of Medical Oncology, Advanced Medical Research Institute, Bhubaneswar, Odisha, India.
Jha S; Department of Pathology and Laboratory Medicine, Advanced Medical Research Institute, Bhubaneswar, Odisha, India.
Lobo A; Department of Pathology and Laboratory Medicine, Advanced Medical Research Institute, Bhubaneswar, Odisha, India.
Panda SP; Department of Pediatric Oncology, Institute of Medical Sciences and SUM Hospital, Bhubaneswar, Odisha, India.
Sharma S; Department of Pathology and Laboratory Medicine, CORE Diagnostics, Gurgaon, Delhi, India.
Kumar M; Department of Pathology and Laboratory Medicine, CORE Diagnostics, Gurgaon, Delhi, India.
Arora S; Department of Pathology and Laboratory Medicine, CORE Diagnostics, Gurgaon, Delhi, India.
Mallik V; Department of Pathology and Laboratory Medicine, CORE Diagnostics, Gurgaon, Delhi, India.
Jain D; Department of Pathology and Laboratory Medicine, CORE Diagnostics, Gurgaon, Delhi, India.
Jain E; Department of Pathology and Laboratory Medicine, CORE Diagnostics, Gurgaon, Delhi, India.
Chakrabarti I; Department of Pathology, AIIMS, Kalyani, West Bengal, India.
Varshney J; Department of Pathology and Laboratory Medicine, CORE Diagnostics, Gurgaon, Delhi, India.
Beg A; Department of Pathology and Laboratory Medicine, CORE Diagnostics, Gurgaon, Delhi, India.
Dixit M; Department of Pathology and Laboratory Medicine, CORE Diagnostics, Gurgaon, Delhi, India.
Baisakh MR; Department of Pathology, Prolife Diagnostics, Bhubaneswar, Odisha, India.
Naik S; Department of Pathology, Prolife Diagnostics, Bhubaneswar, Odisha, India.
Sahoo SK; Department of Pediatric Surgery, Institute of Medical Sciences and SUM Hospital, Bhubaneswar, Odisha, India.
Akgul M; Department of Pathology, Albany Medical Center, Albany, NY, USA.
Balzer BL; Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Amin MB; Department of Pathology and Laboratory, University of Southern California Keck School, Los Angeles, CA, USA.
Parwani AV; Department of Pathology and Laboratory, Wexner Medical Center, Pathology, Columbus, OH, USA.; Pokaż więcej
Źródło:: International journal of surgical pathology [Int J Surg Pathol] 2024 Apr; Vol. 32 (2), pp. 294-303. Date of Electronic Publication: 2023 Jun 13.
Typ publikacji:: Journal Article
MeSH Terms:: Medulloblastoma*
Sarcoma, Synovial*/diagnosis
Sarcoma, Synovial*/genetics
Rhabdomyosarcoma, Embryonal*
Neuroblastoma*/diagnosis
Wilms Tumor*/diagnosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma*
Cerebellar Neoplasms*
Kidney Neoplasms*/diagnosis
Kidney Neoplasms*/genetics
Humans ; Child ; Biomarkers, Tumor ; Diagnosis, Differential ; GATA3 Transcription Factor

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Different Levels of Therapeutic Strategies to Recover the Microbiome to Prevent/Delay Acute Lymphoblastic Leukemia (ALL) or Arrest Its Progression in Children.
Autorzy:: Aronica TS; Complex Operative Unit of Clinical Pathology, ARNAS Civico Di Cristina e Benfratelli Hospitals, 90127 Palermo, Italy.
Carella M; Complex Operative Unit of Clinical Pathology, ARNAS Civico Di Cristina e Benfratelli Hospitals, 90127 Palermo, Italy.
Balistreri CR; Cellular, Molecular and Clinical Pathological Laboratory, Department of Biomedicine, Neuroscience and Advanced Diagnostics (Bi.N.D.), University of Palermo, 90134 Palermo, Italy.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 31; Vol. 25 (7). Date of Electronic Publication: 2024 Mar 31.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Microbiota*
Gastrointestinal Microbiome*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/therapy
Hematologic Neoplasms*
Infant, Newborn ; Humans ; Child ; Fetus

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Metabolic Profiling as an Approach to Differentiate T-Cell Acute Lymphoblastic Leukemia Cell Lines Belonging to the Same Genetic Subgroup.
Autorzy:: Alabed HBR; Department of Chemistry, Biology and Biotechnology, University of Perugia, 06100 Perugia, Italy.
Pellegrino RM; Department of Chemistry, Biology and Biotechnology, University of Perugia, 06100 Perugia, Italy.
Buratta S; Department of Chemistry, Biology and Biotechnology, University of Perugia, 06100 Perugia, Italy.; Centro di Eccellenza sui Materiali Innovativi Nanostrutturati (CEMIN), University of Perugia, Via del Giochetto, 06123 Perugia, Italy.
Lema Fernandez AG; Hematology and Bone Marrow Transplantation Unit, Laboratory of Molecular Medicine (CREO), Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy.
La Starza R; Hematology and Bone Marrow Transplantation Unit, Laboratory of Molecular Medicine (CREO), Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy.
Urbanelli L; Department of Chemistry, Biology and Biotechnology, University of Perugia, 06100 Perugia, Italy.; Centro di Eccellenza sui Materiali Innovativi Nanostrutturati (CEMIN), University of Perugia, Via del Giochetto, 06123 Perugia, Italy.
Mecucci C; Hematology and Bone Marrow Transplantation Unit, Laboratory of Molecular Medicine (CREO), Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy.
Emiliani C; Department of Chemistry, Biology and Biotechnology, University of Perugia, 06100 Perugia, Italy.; Centro di Eccellenza sui Materiali Innovativi Nanostrutturati (CEMIN), University of Perugia, Via del Giochetto, 06123 Perugia, Italy.
Gorello P; Department of Chemistry, Biology and Biotechnology, University of Perugia, 06100 Perugia, Italy.; Centro di Eccellenza sui Materiali Innovativi Nanostrutturati (CEMIN), University of Perugia, Via del Giochetto, 06123 Perugia, Italy.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 31; Vol. 25 (7). Date of Electronic Publication: 2024 Mar 31.
Typ publikacji:: Journal Article
MeSH Terms:: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Adolescent ; Humans ; Child ; Metabolomics ; Cell Line ; Lipids ; T-Lymphocytes

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: A Rare Case of Methemoglobinemia after Ifosfamide Infusion in a 3-Year-Old Patient Treated for T-ALL.
Autorzy:: Suprunowicz M; Department of Pediatric Oncology and Hematology, Medical University of Bialystok, 15-274 Bialystok, Poland.
Marcinkiewicz K; Department of Pediatric Oncology and Hematology, Medical University of Bialystok, 15-274 Bialystok, Poland.
Leszczyńska E; Department of Pediatric Oncology and Hematology, Medical University of Bialystok, 15-274 Bialystok, Poland.
Krętowska-Grunwald A; Department of Pediatric Oncology and Hematology, Medical University of Bialystok, 15-274 Bialystok, Poland.
Płonowski M; Department of Pediatric Oncology and Hematology, Medical University of Bialystok, 15-274 Bialystok, Poland.
Tałałaj M; Department of Anesthesiology and Intensive Care for Children and Adolescents with Postoperative and Pain Treatment Unit, Medical University of Bialystok, 15-274 Bialystok, Poland.
Dakowicz Ł; Department of Pediatric Oncology and Hematology, Medical University of Bialystok, 15-274 Bialystok, Poland.
Krawczuk-Rybak M; Department of Pediatric Oncology and Hematology, Medical University of Bialystok, 15-274 Bialystok, Poland.
Sawicka-Żukowska M; Department of Pediatric Oncology and Hematology, Medical University of Bialystok, 15-274 Bialystok, Poland.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 28; Vol. 25 (7). Date of Electronic Publication: 2024 Mar 28.
Typ publikacji:: Case Reports
MeSH Terms:: Methemoglobinemia*/chemically induced
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*
Male ; Humans ; Child, Preschool ; Ifosfamide/adverse effects ; Methylene Blue/adverse effects ; Catecholamines

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Refining risk prediction in pediatric acute lymphoblastic leukemia through DNA methylation profiling.
Autorzy:: Mosquera Orgueira A; Department of Hematology, University Hospital of Santiago de Compostela, Compostela, Spain. .; Health Research Institute of Santiago de Compostela, Compostela, Spain. .
Krali O; Department of Medical Sciences, Molecular Precision Medicine, Uppsala University, Uppsala, Sweden.; Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Pérez Míguez C; Health Research Institute of Santiago de Compostela, Compostela, Spain.
Peleteiro Raíndo A; Department of Hematology, University Hospital of Santiago de Compostela, Compostela, Spain.; Health Research Institute of Santiago de Compostela, Compostela, Spain.
Díaz Arias JÁ; Department of Hematology, University Hospital of Santiago de Compostela, Compostela, Spain.; Health Research Institute of Santiago de Compostela, Compostela, Spain.
González Pérez MS; Department of Hematology, University Hospital of Santiago de Compostela, Compostela, Spain.; Health Research Institute of Santiago de Compostela, Compostela, Spain.
Pérez Encinas MM; Department of Hematology, University Hospital of Santiago de Compostela, Compostela, Spain.; Health Research Institute of Santiago de Compostela, Compostela, Spain.
Fernández Sanmartín M; Health Research Institute of Santiago de Compostela, Compostela, Spain.; Department of Pediatric Medicine, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain.
Sinnet D; Research Center, CHU Sainte-Justine, Montréal, Canada.; Department of Pediatrics, Université de Montréal, Montreal, Canada.
Heyman M; Childhood Cancer Research Unit, Karolinska Institutet, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.; For the Nordic Society of Pediatric Hematology and Oncology (NOPHO), Stockholm, Sweden.
Lönnerholm G; Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.; For the Nordic Society of Pediatric Hematology and Oncology (NOPHO), Stockholm, Sweden.
Norén-Nyström U; Department of Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden.; For the Nordic Society of Pediatric Hematology and Oncology (NOPHO), Stockholm, Sweden.
Schmiegelow K; Pediatrics and Adolescent Medicine, Rigshospitalet, and the Medical Faculty, Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; For the Nordic Society of Pediatric Hematology and Oncology (NOPHO), Stockholm, Sweden.
Nordlund J; Department of Medical Sciences, Molecular Precision Medicine, Uppsala University, Uppsala, Sweden.; Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; Pokaż więcej
Źródło:: Clinical epigenetics [Clin Epigenetics] 2024 Mar 28; Vol. 16 (1), pp. 49. Date of Electronic Publication: 2024 Mar 28.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: DNA Methylation*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Child ; Humans ; Canada ; Treatment Outcome ; Prognosis ; Recurrence

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: CD19/CD20 dual-targeted chimeric antigen receptor-engineered natural killer cells exhibit improved cytotoxicity against acute lymphoblastic leukemia.
Autorzy:: Yang N; Tissue Engineering and Stem Cell Experiment Center, Guizhou Medical University (GMU), Guiyang, Guizhou, China.; Department of Immunology, College of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China.
Zhang C; Tissue Engineering and Stem Cell Experiment Center, Guizhou Medical University (GMU), Guiyang, Guizhou, China.
Zhang Y; Department of Biology, School of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China.
Fan Y; Tissue Engineering and Stem Cell Experiment Center, Guizhou Medical University (GMU), Guiyang, Guizhou, China.; Department of Immunology, College of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China.
Zhang J; Department of Biology, School of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China.
Lin X; Tissue Engineering and Stem Cell Experiment Center, Guizhou Medical University (GMU), Guiyang, Guizhou, China.; Department of Biology, School of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China.
Guo T; Department of Gynecology, the Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Gu Y; State Key Laboratory of Biotherapy and Cancer Center, Sichuan University, Chengdu, China.
Wu J; Department of Immunology, College of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China.
Gao J; School of Pharmacy, Zunyi Medical University, Zunyi, China.
Zhao X; Tissue Engineering and Stem Cell Experiment Center, Guizhou Medical University (GMU), Guiyang, Guizhou, China. .; Department of Immunology, College of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China. .; Department of Biology, School of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China. .
He Z; Tissue Engineering and Stem Cell Experiment Center, Guizhou Medical University (GMU), Guiyang, Guizhou, China. .; Department of Immunology, College of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China. .; Key Laboratory of Adult Stem Cell Translational Research, Chinese Academy of Medical Sciences), Guiyang, China. .; Department of Pediatrics, the Affiliated Hospital of Zunyi Medical University, Zunyi, China. .; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2024 Mar 13; Vol. 22 (1), pp. 274. Date of Electronic Publication: 2024 Mar 13.
Typ publikacji:: Journal Article
MeSH Terms:: Receptors, Chimeric Antigen*/metabolism
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/metabolism
Mice ; Animals ; Antigens, CD19/genetics ; Antigens, CD19/metabolism ; Cytotoxicity, Immunologic/genetics ; Cell Line, Tumor ; Killer Cells, Natural ; Immunotherapy, Adoptive ; RNA, Messenger/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Leukemia-Lymphoma"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji